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Fibrosarcoma is a mesenchymal tumor composed of malignant fibroblasts. Myxofibrosarcoma is one of the fibrosarcoma variants, and characterized by variable myxoid stroma, pleomorphism, and large curvilinear vascular pattern. This disease is frequent in patients on their 6 th -8 th decade, being rare under the age 20. Most of the patients admit to hospital with a slow developing, painless mass (1) . In most of the cases, tumors are originated from dermal/subcutaneous tissues. Myxofibrosarcomas can be circumscribed or have an infiltrative growth pattern (1) . Generally, these tumors are located in the limbs (especially lower limbs), and rarely on the chest, head, and neck (2).
To best of our knowledge, since there are no reports of myxofibrosarcomas located in the lung, this case was presented.
CASE REPORT
A 47-year-old male patient with chest pain complaints for 4 months and presenting effort dyspnea was admitted to our clinic. There was no pulmonary disease or tuberculosis in his clinical background. Although for 25 years he smoked 1 package of cigarettes a day, this habit had completely ceased 4 months before. In physical examination, the left hemithorax was more convex than the right hemithorax. There was no chest mass. There was an inspiratory rale on the right chest wall. Other examinations were normal. In laboratory analysis the results were white blood cell count (WBC) Thorax computed tomography (CT) revealed that the trachea, both of the main bronchus, the mediastinal main vascular structures, and the heart contour and size were normal. There was no pathologically developed lymph node on the mediastinum. Thorax CT scan indicated a solid mass lesion of 52 x 58 mm in size at the apical segment of the left upper lobe ( Figure 2 ). Other lung parenchymal areas were normal. Cervical disc CT was applied in order to assess costal and vertebral invasion. T 1 , T 2 , T 3 vertebra corpuses were evaluated as normal.
Tru-Cut lung biopsy was performed with CT from the mass. Histopathological evaluation revealed that the tumor was malignant mesenchymal: myxofibrosarcoma ( Figure 3 ).
There was no metastatic lesion detected in abdominal ultrasonography (US), cranial magnetic resonance imaging (MRI), or bone scintigraphy of the patient. Surgery was performed. The neoplasm was composed of cellular fascicles of spindle and pleomorphic tumor cells with numerous, often atypical mitosis, and chest wall areas of hemorrhage and necrosis ( Figure 3 ). Moreover, bizarre, multinucleated giant cells with abundant eosinophi- lic cytoplasm and irregular shaped nuclei was noted. There were necroses on five or six focal points. There were numerous convex vascular structures within the stroma. Immunohistochemical studies of stained tumor cells revealed diffuse positivity for vimentin and focal positivity for actin; desmin S100 and C68 stainings were negative. In histopathological evaluation, no tumor tissue was observed on the paravertebral muscle and costal ribs excised with the mass.
Ifosfamide and adriablastine chemotherapy was planned. The patient was treated by chemotherapy and radiotherapy with totally 60 Gray/30 fractions. After one year, thorax CT evaluation was normal.
DISCUSSION
Malignant fibrous histiocytoma (MFH) is a common subtype of soft tissue sarcomas, and myxofibrosarcoma was described as a distinct variant of MFH by Angervall et al. (3) . Myxofibrosarcoma is one of the most common sarcomas in patients between their 6 th and 8 th decade, with a slight male predominance, as in our case (1, 4) .
The most common presentation of myxofibrosarcoma is a slowly enlarging, painless, subcutaneous swelling (1, 5) . The majority of these tumors arise from the limbs, especially the lower extremities. They are rarely seen on the chest (2,4). A previous report of chest myxofibrosarcoma described cutaneous presentation and dermal involvement (6). Our case consisted of a tumor located in the chest, but growing into the lung, which, as far as we acknowledge, has never been described.
The histological and immunohistochemical features of myxofibrosarcomas are characteristic. Histologic features include: commonly nodular growth pattern; a myxoid matrix containing elongated, curvilinear capillaries; and fusiform, round or stellate tumor cells with indistinct cell margins, slightly eosinophilic cytoplasm, and hyperchromatic atypical nuclei (3, 4) . Immunohistochemically, there is focal actin positivity in a minority of cases. With exception to consistent vimentin staining, all other routinely used markers are negative (1) . Histological and immunohistochemical examinations of our case were characteristic of myxofibrosarcoma.
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These tumors have been subdivided into four grades based on the degree of cellularity, the nuclear pleomorphism, areas of necrosis, and the mitotic activity (4). Our case was established as "grade II myxofibrosarcoma" according to these criteria.
Local recurrences occur in up to 50-60% of the cases independently of histological grading (1). Intermediate -and high-grade neoplasms may develop hematogenous metastases in about 20-35% of the cases (4,7). Additionally, a significant proportion of myxofibrosarcomas that deceivingly appear circumscribed in growth actually present microscopic extension of individual sarcoma cells along the fasicoaponeurotic plane. Tumor progression with increased metastases is frequently seen after relentless local recurrences, especially when resection margins are positive in primary surgery (8) . Therefore, chemotherapy and/or radiotherapy is the recommended approach following surgery (5,7). We planned chemotherapy and radiotherapy in our case.
As conclusion, in myxofibrosarcoma, early diagnosis and surgical treatment are significant for prognosis. Although the tumor can be curable by surgery, local recurrences may occur in 50-60% of the cases. For this reason, chemotherapy and/or radiotherapy can be prescribed to the patients after the surgical procedure.
